BioAlliance Pharma Submits Application for Orphan Medicinal Product Designation for Clonidine Lauriad in Europe and …
Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the supportive care and …
Read more on Finanzen.net

4 PRO PR-Optimization Strategies: SEO, Video, Local & Social
Extra! Extra! Optimize all about it. Is your _________ optimized? Correct answers include: websites, blogs, social media profiles, videos, images, ads, landing pages, analytics, online press releases, tweets, posts, bios, and local directories l…
Read more on Search Engine Watch

Press Release
BioAlliance Pharma SA (Paris:BIO) (Euronext Paris – BIO), a company dedicated to the supportive care and treatment of cancer patients, today announced the submission to the European (EMA) and American (FDA) Drug Agencies of an application for orphan medicinal product designation for clonidine Lauriad™, in the prevention of radiotherapy-induced oral mucositis in patients with head and neck cancer.
Read more on PharmiWeb